UnitedHealth, private equity firm likely buyers in $1.6B Magellan deal

UnitedHealth Group and private equity firm Carlyle Group are front-runners in a bid for pharmacy benefits and behavioral health provider Magellan Health, an SVB Leerink analyst told Business Insider.

Advertisement

An announcement on the deal may arrive in the next month or, at the latest, by the end of September, SVB Leerink analyst Ana Gupte told Business Insider. While Dealreporter first said in April that Anthem was a top contender in the sale, Ms. Grupte said Anthem’s recent acquisition of behavioral health provider Beacon Health Options likely takes the insurer out of the running.

Ms. Gupte anticipates that Magellan will be acquired for roughly $85 to $90 a share. As of June 10, Magellan had a market value of $1.6 billion, according to the report.

Read more here.

More articles on payers:
Anthem to cover some WellStar services, state order says
Q&A: Allina Health | Aetna CEO on the joint venture’s first year
UPMC backpedals on controversial prepayment policy

Advertisement

Next Up in Uncategorized

  • Sacroiliac joint fusion technology is advancing, and the data shows it’s efficacy across different medtech companies. Five notes: 1. Tenon…

  • Robert Mach was appointed CEO of Schoolcraft Memorial Hospital in Manistique, Mich., effective Aug. 15. Mr. Mach brings a wealth…

  • Nashville, Tenn.-based HCA Healthcare, the largest health system in the country, is seeking finance chiefs at four of its hospitals. …

Advertisement

Comments are closed.